{"product_id":"inpatient-anticoagulation-isbn-9780470602119","title":"Inpatient Anticoagulation","description":"\u003cp\u003eThe first practical guide for hospitalists on the use of anticoagulants in hospitalized patients\u003c\/p\u003e \u003cp\u003eThis edited volume provides a comprehensive overview of the vital topic of anticoagulation in the hospital setting. Designed specifically for use by hospital-based clinicians and associated hospital-based staff, this fully evidence-based book addresses the most commonly used anticoagulant agents, the latest advances in anticoagulation drugs, and primary indications for their use at therapeutic levels.\u003c\/p\u003e \u003cp\u003eThis thorough, easy-to-use reference summarizes the most important guidelines and medical literature on anticoagulation. It features a careful review of the epidemiology and treatment of complications associated with anticoagulants. Unique topics include transition of care and practical strategies for developing and implementing quality improvement programs to enhance the administration and safety of anticoagulants.\u003c\/p\u003e \u003cp\u003eThis concise resource also covers:\u003c\/p\u003e \u003cul\u003e \u003cli\u003e \u003cp\u003eAntiplatelet medications\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eThe treatment and prevention of venous thromboembolism in medical patients\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eVenous thromboembolism prophylaxis in surgical patients\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003ePeri-operative management of oral anticoagulants and antiplatelet agents\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003ePrevention of cardioembolic stroke\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eAntithrombotics for ischemic stroke\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eAntithrombotic therapy for non-ST elevation acute coronary syndrome\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eHemorrhagic complications of anticoagulants in hospitalized patients\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eHeparin-induced thrombocytopenia\u003c\/p\u003e \u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eHospitalists and other members of the patient care team will find that Inpatient Anticoagulation answers their questions with dependable and timely information.\u003c\/p\u003e  \u003cb\u003ePreface vii\u003c\/b\u003e  \u003cp\u003e\u003cb\u003eContributors ix\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1. Pharmacology of Parenteral Anticoagulants 1\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eKathleen H. McCool and Daniel M. Witt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2. Pharmacology of Vitamin K Antagonists 25\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eJaekyu Shin and Steven R. Kayser\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3. Antiplatelet Medications 47\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eMichael Kornfeld and Joseph R. Munsayac\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4. Newer Oral Anticoagulants 67\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eTaki Galanis and Geno J. Merli\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5. Prevention of Venous Thromboembolism in Medical Patients 81\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAlex C. Spyropoulos and Charles E. Mahan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6. Prevention of Venous Thromboembolism in Surgical Patients 107\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eNancy Torres Finnerty and Franklin Michota\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7. Treatment of Acute Venous Thromboembolism in Hospitalized Patients 137\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eTracy Minichiello, Lauren Doctoroff, and Elizabeth A. Farrell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8. Perioperative Management of Oral Anticoagulants and Antiplatelet Agents 161\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eRamiro Jervis and Andrew Dunn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9. Prevention of Cardioembolic Stroke 179\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAli Mahajerin and Warren J. Manning\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10. Antithrombotics for Ischemic Stroke 205\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eFadi B. Nahab and Sakib Qureshi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11. Antithrombotic Therapy for Non-ST-Elevation Acute Coronary Syndrome 223\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eDavid Lao and Andrew Boyle\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12. Parenteral Anticoagulants: Special Considerations in Patients with Chronic Kidney Disease and Obesity 241\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eSarah A. Spinler, Millie Rajyaguru, Julie K. Atay, and John Fanikos\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13. Hemorrhagic Complications of Anticoagulants in Hospitalized Patients 291\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAllison Burnett, Jason Cohen, and David A. Garcia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14. Heparin-Induced Thrombocytopenia 331\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eDavid Feinbloom and John Fani Srour\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15. Transitions in Care: Inpatient Anticoagulation 361\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eNeil Gupta, Diane Sliwka, and Margaret C. Fang\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16. Optimizing Inpatient Anticoagulation: Strategies for Quality Improvement 377\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eGreg Maynard, Ian Jenkins, Brian Clay, Michael Montazeri, and Doug Humber\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIndex 415\u003c\/b\u003e\u003c\/p\u003e \"This is a valuable book summarizing the current thought on anticoagulation. In keeping with its premise, it does not cover much of the outpatient realm. This is a significant addition to the knowledge bank for inpatient care.\" (Doody's, 9 March 2012)  \u003cp\u003e\u003cstrong\u003eMargaret C. Fang\u003c\/strong\u003e, MD, MPH, is an academic hospitalist and assistant professor of medicine at the University of California, San Francisco. Her research interest is in how best to prevent stroke in older patients with atrial fibrillation. In particular, her goals are to explore clinical and biological risk factors for stroke, identify the optimal use of anticoagulants to prevent atrial fibrillation-related stroke, and direct attention toward social and behavioral barriers to optimal anticoagulant management. Eventually, she would like to develop interventions directed at improving clinical decision-making regarding anticoagulation therapy for the oldest patients.\u003cbr\u003eDr. Fang trained in internal medicine at the Beth Israel Deaconess Medical Center in Boston and subsequently completed a research fellowship at Massachusetts General Hospital, obtaining a Masters of Public Health. She joined the staff at UCSF in 2003, where she is a practicing hospitalist as well as a clinician-investigator. She is currently part of the ATRIA Study Group, an NIA-funded study of warfarin use and outcomes in a large cohort of patients with atrial fibrillation.   \u003c\/p\u003e\u003cp\u003eThe first practical guide for hospitalists on the use of anticoagulants in hospitalized patients\u003c\/p\u003e \u003cp\u003eThis edited volume provides a comprehensive overview of the vital topic of anticoagulation in the hospital setting. Designed specifically for use by hospital-based clinicians and associated hospital-based staff, this fully evidence-based book addresses the most commonly used anticoagulant agents, the latest advances in anticoagulation drugs, and primary indications for their use at therapeutic levels.\u003c\/p\u003e \u003cp\u003eThis thorough, easy-to-use reference summarizes the most important guidelines and medical literature on anticoagulation. It features a careful review of the epidemiology and treatment of complications associated with anticoagulants. Unique topics include transition of care and practical strategies for developing and implementing quality improvement programs to enhance the administration and safety of anticoagulants.\u003c\/p\u003e \u003cp\u003eThis concise resource also covers:\u003c\/p\u003e \u003cul\u003e \u003cli\u003e \u003cp\u003eAntiplatelet medications\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eThe treatment and prevention of venous thromboembolism in medical patients\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eVenous thromboembolism prophylaxis in surgical patients\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003ePeri-operative management of oral anticoagulants and antiplatelet agents\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003ePrevention of cardioembolic stroke\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eAntithrombotics for ischemic stroke\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eAntithrombotic therapy for non-ST elevation acute coronary syndrome\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eHemorrhagic complications of anticoagulants in hospitalized patients\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eHeparin-induced thrombocytopenia\u003c\/p\u003e \u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eHospitalists and other members of the patient care team will find that Inpatient Anticoagulation answers their questions with dependable and timely information.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989430255845,"sku":"NP9780470602119","price":81.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780470602119.jpg?v=1761784072","url":"https:\/\/k12savings.com\/es\/products\/inpatient-anticoagulation-isbn-9780470602119","provider":"K12savings","version":"1.0","type":"link"}